Heart

Article	Citations
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people	274
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis	186
COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?	154
Pulmonary hypertension and right ventricular involvement in hospitalised patients with COVID-19	150
Place and causes of acute cardiovascular mortality during the COVID-19 pandemic	139
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis	118
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China	96
Prevalence, incidence and survival of heart failure: a systematic review	96
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure	91
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK	89
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management	83
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction	77
Early detection of elevated cardiac biomarkers to optimise risk stratification in patients with COVID-19	76
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis	75
Diagnosis, management and therapeutic strategies for congenital long QT syndrome	75
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities	73
Atrial fibrillation and the prothrombotic state: revisiting Virchow’s triad in 2020	69
Multimodality imaging assessment of mitral annular disjunction in mitral valve prolapse	63
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank	62
Recent advances in percutaneous coronary intervention	58
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017	56
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis	56
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges	54
Arrhythmogenic left ventricular cardiomyopathy	53
Global longitudinal strain: clinical use and prognostic implications in contemporary practice	52

Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation	50
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry	47
Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure	47
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis	46
Adult congenital heart disease and the COVID-19 pandemic	46
Pregnancy in congenital heart disease: risk prediction and counselling	45
Longitudinal associations between loneliness, social isolation and cardiovascular events	44
Systematic review of current natural language processing methods and applications in cardiology	43
Cardiac sarcoidosis: state-of-the-art review	42
Maternal cardiovascular risk after hypertensive disorder of pregnancy	42
Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China	41
Cardiotoxicities of novel cancer immunotherapies	41
Eisenmenger syndrome: diagnosis, prognosis and clinical management	40
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis	39
Sex differences in the association between childhood maltreatment and cardiovascular disease in the UK Biobank	39
Limit of detection of troponin discharge strategy versus usual care: randomised controlled trial	39
Do underlying cardiovascular diseases have any impact on hospitalised patients with COVID-19?	38
Colchicine for acute and chronic coronary syndromes	38
Recreational substance use among patients with premature atherosclerotic cardiovascular disease	38
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic	37
Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic	36
Sacubitril/valsartan in the treatment of systemic right ventricular failure	36
Association of physical activity trajectories with major cardiovascular diseases in elderly people	36
Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection	35
The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial	34
Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation	34
Lipoprotein(a) is robustly associated with aortic valve calcium	33
Contrast-enhanced computed tomography assessment of aortic stenosis	32
Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models	32
Advanced imaging of right ventricular anatomy and function	32
Cardiovascular disease in homeless versus housed individuals: a systematic review of observational and interventional studies	32
Home monitoring with technology-supported management in chronic heart failure: a randomised trial	31
Non-infective endocarditis	31
Artificial intelligence for the echocardiographic assessment of valvular heart disease	31
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial	31
Physical activity and the progression of coronary artery calcification	31
What is ‘normal’ left ventricular ejection fraction?	30
Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease	30
Association of lipoprotein(a) levels with recurrent events in patients with coronary artery disease	30
Cardiac myxomas: clinical presentation, diagnosis and management	29
Diagnostic accuracy of handheld electrocardiogram devices in detecting atrial fibrillation in adults in community versus hospital settings: a systematic review and meta-analysis	29
Socioeconomic status and cardiovascular health in the COVID-19 pandemic	28
Contrast echocardiography: current status and future directions	28
Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice	28
Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic	28
Anakinra for constrictive pericarditis associated with incessant or recurrent pericarditis	28
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation	28
Greater admissions, mortality and cost of heart failure in adults with congenital heart disease	28
New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope	27
Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification	26

Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure	26
Mutations in TRIM63 cause an autosomal-recessive form of hypertrophic cardiomyopathy	26
Clinical outcome of COVID-19 in patients with adult congenital heart disease	26
Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Found	26
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation	26
Income level and outcomes in patients with heart failure with universal health coverage	25
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction	25
Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis	25
MRI and CT coronary angiography in survivors of COVID-19	25
Endocarditis risk with bioprosthetic and mechanical valves: systematic review and meta-analysis	24
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors	24
Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction	24
Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings	24
Right ventricle in heart failure with preserved ejection fraction	24
Survival and risk of recurrence of takotsubo syndrome	24
Early clinical and haemodynamic matched comparison of balloon-expandable valves	24
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis	23
Atrial fibrillation: global burdens and global opportunities	23
Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level	23
Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy	23
Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014	23
Epicardial adipose tissue in obesity-related cardiac dysfunction	23
Association between right ventricle dysfunction and poor outcome in patients with septic shock	23
Brugada syndrome: update and future perspectives	23
Sexism experienced by consultant cardiologists in the United Kingdom	23
Transcatheter management of severe aortic stenosis during the COVID-19 pandemic	23
Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression	22
Update on management of atrial fibrillation in heart failure: a focus on ablation	22
Quality of life and healthcare utilisation improvements after atrial fibrillation ablation	22
Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly	22
Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation	22
Clinical outcomes in spontaneous coronary artery dissection	21
Anticoagulant prescribing for atrial fibrillation and risk of incident dementia	21
Heart failure medication dosage and survival in women and men seen at outpatient clinics	21
Association of heart failure and its comorbidities with loss of life expectancy	21
Ramadan fasting: recommendations for patients with cardiovascular disease	21
Risk of infective endocarditis after surgical and transcatheter aortic valve replacement	21
Contemporary demographics, diagnostics and outcomes in non-bacterial thrombotic endocarditis	21
Cardiovascular outcomes of pregnancy in Turner syndrome	21
Prediction of adverse cardiac events in pregnant women with valvular rheumatic heart disease	21
Air pollution and cardiovascular disease: the Paul Wood Lecture, British Cardiovascular Society 2021	21
Comprehensive review of evaluation and management of cardiac paragangliomas	21
Neurocognitive and psychosocial outcomes in adult congenital heart disease: a lifespan approach	21
Computed tomographic myocardial mass compared with invasive myocardial perfusion measurement	20
The ‘wait for symptoms’ strategy in asymptomatic severe aortic stenosis	20
Early cardiac magnetic resonance imaging in troponin-positive acute chest pain and non-obstructed coronary arteries	20
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure	20
Sex differences in prevalence, treatment and control of cardiovascular risk factors in England	20
Socioeconomic disparities in prehospital factors and survival after out-of-hospital cardiac arrest	20
What is the normal composition of pericardial fluid?	20
Utility of 3D printed cardiac models in congenital heart disease: a scoping review	20
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials	20
Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation	19
Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis	19
Left ventricular non-compaction cardiomyopathy: how many needles in the haystack?	19
Assessment and management of peripheral arterial disease: what every cardiologist should know	19
Primary prevention of cardiovascular disease in women with a Mediterranean diet: systematic review and meta-analysis	19
Machine learning model for predicting out-of-hospital cardiac arrests using meteorological and chronological data	19
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome	19
Aortitis: recent advances, current concepts and future possibilities	19
Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults	19
Regional variation in cardiovascular magnetic resonance service delivery across the UK	19
Getting the best from the Heart Team: guidance for cardiac multidisciplinary meetings	19
National Institute for Health and Care Excellence (NICE) guidance on heart valve disease	19
Temporal trends and sex differences in sudden cardiac death in the Copenhagen City Heart Study	18
Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease	18
Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention	18
Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysis	18
Improvement of ejection fraction and mortality in ischaemic heart failure	18
Familial hypercholesterolaemia: history, diagnosis, screening, management and challenges	17
Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction	17
Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure	17
Hypereosinophilic syndrome: considerations for the cardiologist	17
Role of echocardiography in screening and evaluation of athletes	17
Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care	17
Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women	17
Pregnancy outcomes in women with aortic coarctation	17
Considering complexity in the genetic evaluation of dilated cardiomyopathy	17
Outcome and durability of mitral valve annuloplasty in atrial secondary mitral regurgitation	17
Novel bradycardia pacing strategies	17

Personalised external aortic root support for elective treatment of aortic root dilation in 200 patients	17
Determinants of clinical outcomes of surgery for isolated severe tricuspid regurgitation	17
MINOCA: a heterogenous group of conditions associated with myocardial damage	17
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis	17
Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain	17
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation	16
Predicting sudden cardiac death in adults with congenital heart disease	16
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis	16
Cardiovascular magnetic resonance imaging: emerging techniques and applications	16
Association between combat-related traumatic injury and cardiovascular risk	16
Temporal association between invasive procedures and infective endocarditis	16
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease	16
Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat	16
Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function: systematic review and meta-analysis	16
Prognostic impact of cardiac surgery in left-sided infective endocarditis according to risk profile	16
Pathogen influence on epidemiology, diagnostic evaluation and management of infective endocarditis	16
Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis	16
Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke	16
D-dimer and the incidence of heart failure and mortality after acute myocardial infarction	16
Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC)	15
National Institute for Health and Care Excellence clinical guidelines development principles and processes	15
Excessive daytime sleepiness: an emerging marker of cardiovascular risk	15
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention	15
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target	15
Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure	15
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response	15
Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank	15
Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia	15
N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy	15
The enigmatic immunoglobulin G4-related disease and its varied cardiovascular manifestations	14
Community pharmacy-based study of adherence to non-vitamin K antagonist oral anticoagulants	14
Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation	14
Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis	14
Diabetes and coronary artery disease: not just a risk factor	14
Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation	14
Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions	14
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation	14
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer	14
Effect of blood pressure lowering drugs and antibiotics on abdominal aortic aneurysm growth: a systematic review and meta-analysis	14
Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses	14
Incident aortic stenosis in 49 449 men and 42 229 women investigated with routine echocardiography	14
Comparative effectiveness of oral anticoagulants in everyday practice	14
Nickel hypersensitivity and endovascular devices: a systematic review and meta-analysis	14
Positron emission tomography imaging in cardiovascular disease	14
Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty	14
Evaluation of indicators supporting reproducibility and transparency within cardiology literature	14
Preterm birth and cardiac function in adulthood	14
Fried-food consumption and risk of cardiovascular disease and all-cause mortality: a meta-analysis of observational studies	13
Evaluation of the causes of sex disparity in heart failure trials	13
Challenges in the management of older patients with acute coronary syndromes in the COVID-19 pandemic	13
Spondylodiscitis complicating infective endocarditis	13
Relative survival after aortic valve surgery in patients with bicuspid aortic valves	13
Postmenopausal hormone therapy for cardiovascular health: the evolving data	13
Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial	13
Sex differences in sudden cardiac death in a nationwide study of 54 028 deaths	13
Sudden cardiac death in asymptomatic patients with aortic stenosis	13
Chronobiological patterns of acute aortic dissection in central China	13
Association between age at onset of overweight and risk of hypertension across adulthood	13
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis	13
D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation	13
Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study	13
Clinical outcomes of children with rheumatic heart disease	13
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease	13
Prognostic value of C-reactive protein in adults with congenital heart disease	13
Multiple arterial coronary bypass grafting is associated with greater survival in women	13
The new role of diagnostic angiography in coronary physiological assessment	13
Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy	13
Trimethylamine oxide: a potential target for heart failure therapy	13
Opportunities and challenges of implementing computed tomography fractional flow reserve into clinical practice	13
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort	12
Nuclear cardiology: state of the art	12
Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance	12
Flattening the curve in COVID-19 using personalised protective equipment: lessons from air pollution	12
Counterpoint: challenges and limitations of transcatheter aortic valve implantation for aortic regurgitation	12
Methamphetamine-associated heart failure: a systematic review of observational studies	12
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy	12
Improving detection and management of familial hypercholesterolaemia in Australian general practice	12
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden	12
Anatomy of the mitral valve relative to controversies concerning the so-called annular disjunction	12
Evidence base for the management of women with non-ST elevation acute coronary syndrome	12
Infective endocarditis at a tertiary care hospital in South Korea	12
Vaping and cardiac disease	12
Mental disorders and cardiovascular disease: what should we be looking out for?	12
Prognostic role of PET/MRI hybrid imaging in patients with pulmonary arterial hypertension	11
Cohort study of intervened functionally univentricular heart in England and Wales (2000–2018)	11
Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know	11
Antithrombotic therapy for patients with chronic coronary syndromes	11
Survival of people with valvular heart disease in a large, English community-based cohort study	11
Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation	11
Role of beta blockers following percutaneous coronary intervention for acute coronary syndrome	11
Lipoprotein-associated phospholipase A2 activity, genetics and calcific aortic valve stenosis in humans	11
Establishing reference ranges for ambulatory electrocardiography parameters: meta-analysis	11
Cost-effectiveness of cardiovascular imaging for stable coronary heart disease	11
Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle	11
Shared decision making in cardiology: a systematic review and meta-analysis	11